Research > ETFs > ETF / ETP Commentary > 

3 Surprising Emerging Market ETFs That Starred This Year

Just a few weeks stand between markets and the start of a whole new year. That means investors can start taking stock of 2026 ahead of a new year. Emerging market ETFs provide a release valve for portfolios away from expensive U.S. stocks, with healthy upside of their own. ETF Database’s top three emerging markets this year include some surprising names, starting with the Nomura ETF Trust Nomura Focused Emerging Markets Equity ETF (EMEQ B+).Key Takeaways: The top three ETFs by YTD performance, with a minimum AUM of $100 million, include surprises. KEMX, EMEQ, and FTHF offer roughly different approaches, with all allocated to East Asia equities. The trio could help portfolios diversify away from U.S. concentration risk and offer upside. EMEQ charges an 85 basis point (bps) fee for an active approach to emerging market ETFs. The strategy, according to ETF Database data, posted the highest YTD return — 34.75% — among emerging market ETFs as of November 19. The fund provides exposure to a narrow list of high-conviction emerging market equities with a bottom-up, fundamental approach. EMEQ launched in September 2024, positioning it for its three-year ETF milestone next year. It has a heavy allocation toward South Korea and other East Asia tech firms in the broader semiconductor and tech supply chain.Intriguing Names to WatchThe top three of emerging market ETFs with more than $100 million in AUM also includes the First Trust Emerging Markets Human Flourishing ETF (FTHF B+). It charges a 75 bps fee for its take on emerging market equities. The strategy tracks a market-cap-weighted index of large- and midsize firms promoting human flourishing based on a score. The fund has returned 21.6% YTD, putting it third-best among emerging market ETFs for that period per November 19. Its one-year return has been better, at 32.6% as of the same date per ETF Database. While it too allocates to South Korea tech, it also has notable investments in South Africa and Brazil. See more: Diversify Into Discounts: International ETF TOUS Rises Finally, the KraneShares MSCI Emerging Markets ex China Index ETF (KEMX C) can intrigue. It charges a 24 bps fee, the lowest of the three, and has returned 19.6% YTD. The fund has returned 26.5% over one year, per ETF DB, as well. Additionally, the fund provides exposure to East Asia emerging markets, largely, while excluding China. Together, those three funds provide some intriguing names to watch outside of the biggest funds. For those looking to diversify out of the AI stocks tumult in U.S. equities, emerging markets can appeal. For more news, information, and analysis, visit the Equity ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.